Zevra Therapeutics Ownership | Who Owns Zevra Therapeutics?
Zevra Therapeutics Ownership Summary
Zevra Therapeutics is owned by 42.48% institutional investors, 1.30% insiders, and 56.23% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.06% of ZVRA shares.
ZVRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zevra Therapeutics | 42.48% | 1.30% | 56.23% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 4.51M | 8.06% | $40.38M |
| Woodline partners lp | 3.48M | 6.35% | $33.06M |
| Vanguard group | 3.31M | 5.91% | $29.61M |
| Adage capital partners gp | 2.23M | 4.06% | $21.16M |
| Altium capital management lp | 1.85M | 3.87% | $15.43M |
| Nantahala capital management | 1.77M | 3.17% | $15.88M |
| Fmr | 1.63M | 2.98% | $15.54M |
| State street | 1.43M | 2.61% | $13.57M |
| Geode capital management | 1.34M | 2.40% | $12.02M |
| Morgan stanley | 1.16M | 2.07% | $10.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 810.00K | 6.26% | $7.70M |
| Altium capital management lp | 1.85M | 4.38% | $15.43M |
| Retirement planning co of new england | 662.98K | 2.38% | $5.94M |
| Kingdon capital management | 650.00K | 0.77% | $6.18M |
| Mystic asset management | 346.53K | 0.70% | $3.10M |
| Nantahala capital management | 1.77M | 0.52% | $15.88M |
| Propel bio management | 63.68K | 0.49% | $570.60K |
| 683 capital management | 975.00K | 0.48% | $9.27M |
| Pharvision advisers | 66.73K | 0.36% | $634.63K |
| Stoneridge investment partners | 32.79K | 0.20% | $294.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 912.30K | 0.01% | 912.30K |
| Morgan stanley | 1.16M | 0.00% | 601.96K |
| Caption management | 510.09K | 0.04% | 510.09K |
| Blackrock funding, inc. /de | 4.51M | 0.00% | 469.90K |
| Tudor investment corp et al | 447.90K | 0.01% | 447.90K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rubric capital management lp | - | - | -1.96M |
| Adage capital partners gp | 2.23M | 0.03% | -1.94M |
| Aigh capital management | - | - | -1.23M |
| Woodline partners lp | 3.48M | 0.16% | -1.14M |
| Velan capital investment management lp | - | - | -715.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 912.30K | 0.01% | 912.30K | $8.68M |
| Tudor investment corp et al | 447.90K | 0.01% | 447.90K | $4.26M |
| Algert global | 418.55K | 0.07% | 418.55K | $3.98M |
| Trexquant investment lp | 302.86K | 0.03% | 302.86K | $2.88M |
| Dimensional fund advisors lp | 154.47K | 0.00% | 154.47K | $1.38M |
Sold Out
| Holder | Change |
|---|---|
| Thompson investment management | -1.00 |
| Capital performance advisors llp | -40.00 |
| Srs capital advisors | -87.00 |
| Wealthspire advisors | -101.00 |
| Ronald blue trust | -121.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 114 | -35.96% | 23,766,788 | -40.43% | 42 | 0.80% | 57 | -46.73% | 30 | -21.05% |
| Sep 30, 2025 | 169 | 42.02% | 39,764,013 | 12.97% | 72 | 1.76% | 101 | 55.38% | 37 | 37.04% |
| Jun 30, 2025 | 125 | 6.84% | 36,154,652 | 1.99% | 65 | 1.54% | 68 | 15.25% | 28 | -3.45% |
| Mar 31, 2025 | 116 | 2.65% | 35,432,635 | 4.54% | 65 | 1.30% | 58 | -13.43% | 29 | 70.59% |
| Dec 31, 2024 | 53 | -54.31% | 11,658,947 | -59.74% | 24 | 0.66% | 24 | -63.64% | 8 | -55.56% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 09, 2026 | McFarlane Neil F. | President and CEO | Sell | $125.19K |
| Feb 03, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | $27.55K |
| Feb 03, 2026 | Schafer Joshua | CCO | Sell | $96.50K |
| Jan 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | $15.44K |
| Jan 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell | $36.01K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | 1 |
| 2025 Q1 | 2 | 5 |
ZVRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools